Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Mitchell | Genex Sign Agreement to Acquire Coventry 3-2-20
Workers' Comp
Virtual Event
Webinar: Aging Workforce, Medication Safety and Cyber Security
On-Demand
Over the past 10 years, workers' compensation claim frequency has been steadily decreasing, but at the same time, severity has been on the rise and
Workers' Comp
News Release
Business Insurance: Insurers could face stiff Medicare secondary payer penalties
A long-awaited proposed rule regarding late reporting of Medicare Secondary Payer data could mean potentially significant penalties for worke
Workers' Comp
Article
Return to Work Program Benefits & Strategies
Developing successful return to work (RTW) plans is instrumental to efficient and effective workers’ compensation claims management.
Mitchell
News Release
Mitchell Announces Third Party Medicare Module Available in DecisionPoint Platform
Workers' Comp
Article
CMS Announces Proposed Methods to Calculate Civil Monetary Penalties for Section 111 Reporting
Keep current with new legislation and its potential effect on your organization.